Aflatoxin B1 induces subtle but coordinated histone modifications in Epstein-Barr virus infected and non-infected Burkitt lymphoma cells
Environment International · 2025
DOI: 10.1016/j.envint.2025.109813 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environment International, 2025. Verfasst von Thanos M Michailidis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Excellence in Mycotoxicology and Public Health, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium; Epigenomics and Mecha…. Hauptthemen laut MEDLINE: Burkitt Lymphoma, Herpesvirus 4, Human, Aflatoxin B1, Histones. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: World Health Organization, Universiteit Gent, HORIZON EUROPE European Research Council.
Abstract (Originalsprache)
Aflatoxin B1 (AFB1), a potent dietary carcinogen, and Epstein-Barr virus (EBV), an oncogenic virus, are both implicated in cancer development, particularly in endemic regions. However, the combined effects of AFB1 exposure and EBV infection on the epigenetic landscape remain poorly understood. This study investigates the impact of AFB1 and EBV on histone post-translational modifications (hPTMs) in Burkitt lymphoma (BL) cells through an integrative approach combining untargeted mass spectrometry-based profiling and a time-lapse experimental design. Our results reveal subtle, yet reproducible and dynamic alterations in histone methylation and acetylation patterns over time in all cells. Specifically, AFB1 exposure induced an increase in H3K27me3 levels, which in the case of EBV infected cells, counteracts the decrease observed at baseline compared to uninfected cells. Additionally, changes in acetylation patterns of H4 N-tail residues and key regulatory proteins suggest potential disruptions in chromatin accessibility and transcriptional regulation. Our correlation and network-based analyses further highlight coordinated epigenetic shifts in response to AFB1, with key acetylation hubs emerging within the histone PTM profile. Despite subtle differences, no significant divergence in overall hPTM responses was detected between EBV-infected and uninfected cells, emphasizing the subtlety of the EBV effect on AFB1 exposure. Future research should explore locus-specific epigenetic changes and therapeutic interventions targeting hPTMs to mitigate cancer risk associated with AFB1 exposure and EBV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre of Excellence in Mycotoxicology and Public Health, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer/World Health…
- CRIG, Cancer Research Institute Ghent, Ghent, Belgium; Laboratory of Pharmaceutical Biotechnology, Faculty of Pharmaceutical Sciences, Ghent University, Gent, Belgium.
- Centre of Excellence in Mycotoxicology and Public Health, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium; CRIG, Cancer Research Institute Ghent, Ghent, Belgium.
- Epigenomics and Mechanisms Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France; Institute of Cancer Research and Genomic Sciences, University of Birmingham, Birmingham, United Kin…
- Epigenomics and Mechanisms Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.
- Centre of Excellence in Mycotoxicology and Public Health, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium; CRIG, Cancer Research Institute Ghent, Ghent, Belgium; Department of Biotechnology and Food…
Förderung
- World Health Organization
- Universiteit Gent
- HORIZON EUROPE European Research Council
- Horizon 2020 Framework Programme
- European Research Council
- Research Foundation Flanders
Zitieren
APA
Michailidis, T. M., Corveleyn, L., Almey, R., Bader, Y., Odongo, G. A., Herceg, Z., Khoueiry, R., Saeger, S., Boevre, M., & Dhaenens, M. (2025). Aflatoxin B1 induces subtle but coordinated histone modifications in Epstein-Barr virus infected and non-infected Burkitt lymphoma cells. Environment International. https://doi.org/10.1016/j.envint.2025.109813
Vancouver
Michailidis TM, Corveleyn L, Almey R, Bader Y, Odongo GA, Herceg Z, et al. Aflatoxin B1 induces subtle but coordinated histone modifications in Epstein-Barr virus infected and non-infected Burkitt lymphoma cells. Environment International. 2025. doi:10.1016/j.envint.2025.109813
BibTeX
@article{Michailidis2025,
author = {Michailidis, Thanos M and Corveleyn, Laura and Almey, Ruben and Bader, Yasmine and Odongo, Grace A and Herceg, Zdenko and Khoueiry, Rita and Saeger, Sarah De and Boevre, Marthe De and Dhaenens, Maarten},
title = {Aflatoxin B1 induces subtle but coordinated histone modifications in Epstein-Barr virus infected and non-infected Burkitt lymphoma cells},
journal = {Environment International},
year = {2025},
doi = {10.1016/j.envint.2025.109813}
}
EUVIMED